Two series of analogues of 9-propionyl-10-cinnamyl-9,10-diazatricyclo[4.2.1.12,5]decane (1a) and 2-propionyl-7-cinnamyl-2,7-diazatricyclo[4.4.0.03,8]decane (2a), in which the cinnamyl moiety was replaced by various aralkenyl chains, 1b-l and 2b-l, respectively, have been synthesized and evaluated for their ability to bind to the opioid μ-, δ- and κ-receptors. The binding data indicated that compounds 1b,d,e,h and 2b,d,e,f,h,i showed a μ-affinity in the low nanomolar range with moderate or negligible affinity towards δ- and κ-receptors. Selected DTDs, the pairs 1,2b, 1,2e and 1,2h, were also evaluated for analgesic effect. In the hot plate test, only 1b given ip was found to have similar opioid antinociception and chronic tolerance as morphine.

Synthesis of novel diazatricyclodecanes (DTDs). Effects of structural variation at the C3′ allyl end and at the phenyl ring of the cinnamyl chain on μ-receptor affinity and opioid antinociception / G.A. Pinna, G. Cignarella, S. Ruiu, G. Loriga, G. Murineddu, S. Villa, G.E. Grella, G. Cossu, W. Fratta. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - 11:18(2003 Sep), pp. 4015-4026.

Synthesis of novel diazatricyclodecanes (DTDs). Effects of structural variation at the C3′ allyl end and at the phenyl ring of the cinnamyl chain on μ-receptor affinity and opioid antinociception

G. Cignarella;S. Villa;
2003

Abstract

Two series of analogues of 9-propionyl-10-cinnamyl-9,10-diazatricyclo[4.2.1.12,5]decane (1a) and 2-propionyl-7-cinnamyl-2,7-diazatricyclo[4.4.0.03,8]decane (2a), in which the cinnamyl moiety was replaced by various aralkenyl chains, 1b-l and 2b-l, respectively, have been synthesized and evaluated for their ability to bind to the opioid μ-, δ- and κ-receptors. The binding data indicated that compounds 1b,d,e,h and 2b,d,e,f,h,i showed a μ-affinity in the low nanomolar range with moderate or negligible affinity towards δ- and κ-receptors. Selected DTDs, the pairs 1,2b, 1,2e and 1,2h, were also evaluated for analgesic effect. In the hot plate test, only 1b given ip was found to have similar opioid antinociception and chronic tolerance as morphine.
Settore CHIM/08 - Chimica Farmaceutica
set-2003
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0968089603003730-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 388.01 kB
Formato Adobe PDF
388.01 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/693809
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 13
  • ???jsp.display-item.citation.isi??? ND
social impact